🇺🇸 FDA
Patent

US 10358419

1,3-dipolar [70]fulleropyrrolidinium iodide derivatives

granted A61KA61K31/403

Quick answer

US patent 10358419 (1,3-dipolar [70]fulleropyrrolidinium iodide derivatives) held by The Board of Regents of the University of Texas System expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/403